EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post‐Valve Replacement Mortality

Micha T Maeder iD, Alexander Breuss, Sharon Appert, Simon Wildermuth, Philipp K Haager, Johannes Rigger, Joannis Chronis, Martin O Schmiady, Hans Rickli, Lukas Weber

Clinical Cardiology · 2025-12 · 48 (12)

DOI: 10.1002/clc.70225 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Cardiology, online erschienen am 29.11.2025. Verfasst von Micha T Maeder und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, HOCH Health Ostschweiz, Kantonsspital St. Gallen, St. Gallen, Switzerland. Hauptthemen laut MEDLINE: Aortic Valve Stenosis, Hemodynamics, Heart Valve Prosthesis Implantation, Sodium Potassium Chloride Symporter Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Loop diuretic therapy (LDT) is associated with increased mortality in heart failure. Severe aortic stenosis (AS) patients are at risk for heart failure and frequently on LDT. We assessed cardiac structure and function, organ congestion, filling pressures, and long‐term outcomes of severe AS patients on LDT undergoing aortic valve replacement (AVR).

Methods

Consecutive patients with severe AS with [ n = 157; median (interquartile range) daily torasemide dose: 10 (5–15) mg] or without ( n = 346) LDT undergoing a detailed assessment of congestion (B‐type natriuretic peptide, liver enzymes, systematic chest X‐ray analysis) and cardiac catheterization before AVR with a post‐AVR follow‐up of several years were studied.

Results

Despite similar AS severity (indexed aortic valve area 0.41 ± 0.12 vs. 0.43 ± 0.12 cm 2 /m 2 ) patients with LDT had more advanced biventricular remodeling and dysfunction, higher B‐type natriuretic peptide [446 (245–991) vs. 150 (62–317) ng/L; p < 0.001], higher liver enzymes, higher chest x‐ray congestion score [2 (1–4.5) vs. 1 (0–2) score points; p < 0.001], and higher mean right atrial pressure (8 ± 4 vs . 6 ± 3 mmHg) and mean pulmonary artery wedge pressure (21 ± 8 vs. 14 ± 6 mmHg; p < 0.001 for both) than those without. After a median post‐AVR follow‐up of 15 months functional capacity was worse, and estimated systolic pulmonary pressure was higher (37 ± 11 vs . 32 ± 8 mmHg; p < 0.001), and after a median follow‐up of 44 months mortality was higher [hazard ratio 2.01 (95% confidence interval 1.17–3.77); p = 0.01] in LDT compared to non‐LDT patients.

Conclusions

LDT identifies AS patients with more advanced cardiac remodeling, more severe congestion, unfavorable hemodynamics, impaired post‐AVR status, and increased post‐AVR long‐term mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aortic Valve StenosisHemodynamicsHeart Valve Prosthesis ImplantationSodium Potassium Chloride Symporter InhibitorsAortic ValveHumansMaleFemaleAgedSeverity of Illness IndexFollow-Up StudiesTreatment OutcomeTime FactorsRetrospective StudiesSurvival RateAged, 80 and overRisk Factors

Stichwörter der Autor:innen

aortic stenosiscongestiondiureticvalve replacement

Substanzen

Sodium Potassium Chloride Symporter Inhibitors

Autor:innen und Institutionen

  • Department of Cardiology, HOCH Health Ostschweiz, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • University of Basel, Basel, Switzerland.
  • Clinic of Intensive Care, University Hospital Zürich, Zürich, Switzerland.
  • Department of Radiology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
  • Clinic of Cardiac Surgery, University Hospital Zürich, Switzerland.
  • Departmentof Cardiology and Cardio-Vascular Surgery, Hôspital Cardiologique de Haut-Lévêque, Bordeaux University Hospital, France.

ORCID-Profile: Micha T Maeder

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Maeder, M. T., Breuss, A., Appert, S., Wildermuth, S., Haager, P. K., Rigger, J., Chronis, J., Schmiady, M. O., Rickli, H., & Weber, L. (2025). Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post‐Valve Replacement Mortality. Clinical Cardiology, 48(12). https://doi.org/10.1002/clc.70225

Vancouver

Maeder MT, Breuss A, Appert S, Wildermuth S, Haager PK, Rigger J, et al. Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post‐Valve Replacement Mortality. Clinical Cardiology. 2025;48(12). doi:10.1002/clc.70225

BibTeX
@article{Maeder2025,
  author = {Maeder, Micha T and Breuss, Alexander and Appert, Sharon and Wildermuth, Simon and Haager, Philipp K and Rigger, Johannes and Chronis, Joannis and Schmiady, Martin O and Rickli, Hans and Weber, Lukas},
  title = {Loop Diuretic Therapy in Severe Aortic Stenosis: Marker of Organ Congestion, Unfavorable Hemodynamics, and Increased Post‐Valve Replacement Mortality},
  journal = {Clinical Cardiology},
  year = {2025},
  volume = {48},
  number = {12},
  doi = {10.1002/clc.70225}
}
Kostenlos starten →